VIRTUAL CLINICAL TRIALS IN MEDICAL IMAGING SYSTEM EVALUATION AND OPTIMISATION.
Journal
Radiation protection dosimetry
ISSN: 1742-3406
Titre abrégé: Radiat Prot Dosimetry
Pays: England
ID NLM: 8109958
Informations de publication
Date de publication:
12 Oct 2021
12 Oct 2021
Historique:
received:
31
10
2020
revised:
14
04
2021
accepted:
21
04
2021
pubmed:
19
6
2021
medline:
15
10
2021
entrez:
18
6
2021
Statut:
ppublish
Résumé
Virtual clinical trials (VCTs) can be used to evaluate and optimise medical imaging systems. VCTs are based on computer simulations of human anatomy, imaging modalities and image interpretation. OpenVCT is an open-source framework for conducting VCTs of medical imaging, with a particular focus on breast imaging. The aim of this paper was to evaluate the OpenVCT framework in two tasks involving digital breast tomosynthesis (DBT). First, VCTs were used to perform a detailed comparison of virtual and clinical reading studies for the detection of lesions in digital mammography and DBT. Then, the framework was expanded to include mechanical imaging (MI) and was used to optimise the novel combination of simultaneous DBT and MI. The first experiments showed close agreement between the clinical and the virtual study, confirming that VCTs can predict changes in performance of DBT accurately. Work in simultaneous DBT and MI system has demonstrated that the system can be optimised in terms of the DBT image quality. We are currently working to expand the OpenVCT software to simulate MI acquisition more accurately and to include models of tumour growth. Based on our experience to date, we envision a future in which VCTs have an important role in medical imaging, including support for more imaging modalities, use with rare diseases and a role in training and testing artificial intelligence (AI) systems.
Identifiants
pubmed: 34144597
pii: 6304956
doi: 10.1093/rpd/ncab080
pmc: PMC8507451
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
363-371Subventions
Organisme : Breast Cancer Research Foundation
ID : W81XWH-18-1-0082
Organisme : Susan G. Komen
ID : IIR-13262248
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA154444
Pays : United States
Organisme : Horizon 2020
ID : IF 846540
Organisme : NIH HHS
ID : R01 CA154444
Pays : United States
Organisme : Burroughs Wellcome Fund
ID : IRSA 1016451
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Breast Cancer Res Treat. 2013 Sep;141(2):187-95
pubmed: 23990353
IEEE Trans Med Imaging. 2006 Feb;25(2):188-97
pubmed: 16468453
Phys Med Biol. 2017 Mar 21;62(6):2376-2397
pubmed: 28151431
J Med Imaging (Bellingham). 2020 Jul;7(4):042804
pubmed: 32341939
Radiology. 2013 Jan;266(1):104-13
pubmed: 23169790
Med Phys. 2016 Jun;43(6):2704-2714
pubmed: 27277017
Radiat Prot Dosimetry. 2016 Jun;169(1-4):151-7
pubmed: 26410768
Phys Med Biol. 2015 Feb 7;60(3):1259-88
pubmed: 25591807
Eur Radiol. 2014 Sep;24(9):2227-35
pubmed: 24895040
J Med Imaging (Bellingham). 2020 Jul;7(4):042806
pubmed: 32509918
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9758-65
pubmed: 8234311
AJR Am J Roentgenol. 2021 Feb;216(2):362-368
pubmed: 32822224
Acad Radiol. 2006 Mar;13(3):353-62
pubmed: 16488848
Med Phys. 2013 May;40(5):051914
pubmed: 23635284
Med Phys. 2012 Apr;39(4):2290-302
pubmed: 22482649
Radiat Prot Dosimetry. 2005;114(1-3):395-8
pubmed: 15933144
JAMA Netw Open. 2018 Nov 2;1(7):e185474
pubmed: 30646401
Acta Radiol. 2012 Nov 1;53(9):973-80
pubmed: 22949732
J Biomech Eng. 2012 Jan;134(1):011005
pubmed: 22482660
JAMA Netw Open. 2020 Mar 2;3(3):e201965
pubmed: 32202640
Radiat Prot Dosimetry. 2005;114(1-3):81-4
pubmed: 15933085
Radiat Prot Dosimetry. 2005;114(1-3):359-63
pubmed: 15933137